GEMAYEL GEORGES sold 40.8% of their position (18.79K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.00M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/9/2026ACC: 0001256088-26-000006
Director
Since Feb 2026
-18.79K
Net shares
Net seller
$1.00M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
7.91K acquired · 26.69K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−10K
Price / share
$53.71
Trade value
$537.10K
% of position
26.2%
3/5/2026
38.16K→28.16K
Common Stock
Direct
Shares
+7.91K
Price / share
$25.30
Trade value
$200K
% of position
28.1%
3/6/2026
28.16K→36.06K
Common Stock
Direct
Shares
−8.79K
Price / share
$53.00
Trade value
$465.71K
% of position
24.4%
3/6/2026
36.06K→27.28K
Total
Net shares
−10.88K
Net value
-$802.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/5/2026 | S · Sale | −10K | $53.71 | $537.10K | 26.2% | 38.16K | 28.16K |
| Common Stock Direct | 3/6/2026 | M · Option Exercise | +7.91K | $25.30 | $200K | 28.1% | 28.16K | 36.06K |
| Common Stock Direct | 3/6/2026 | S · Sale | −8.79K | $53.00 | $465.71K | 24.4% | 36.06K | 27.28K |
| Total | −10.88K | -$802.81K | ||||||
Derivative Transactions1
Director Stock Option (Right to Buy)
Direct
Converts to
Common Stock
7.91K shares
Shares
−7.91K
Strike price
25.30
Held after
0.00
Exercisable
—
3/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) Direct | Common Stock7.91K shares | 3/6/2026 | M · Option Exercise | −7.91K | 25.30 | — | 0.00 |